concord 发表于 2025-3-21 18:00:18
书目名称Chemokines in Disease影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0224917<br><br> <br><br>书目名称Chemokines in Disease影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0224917<br><br> <br><br>书目名称Chemokines in Disease网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0224917<br><br> <br><br>书目名称Chemokines in Disease网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0224917<br><br> <br><br>书目名称Chemokines in Disease被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0224917<br><br> <br><br>书目名称Chemokines in Disease被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0224917<br><br> <br><br>书目名称Chemokines in Disease年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0224917<br><br> <br><br>书目名称Chemokines in Disease年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0224917<br><br> <br><br>书目名称Chemokines in Disease读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0224917<br><br> <br><br>书目名称Chemokines in Disease读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0224917<br><br> <br><br>Accord 发表于 2025-3-21 21:32:17
978-1-4757-4762-1Springer Science+Business Media New York 1999Deadpan 发表于 2025-3-22 03:14:34
Contemporary Immunologyhttp://image.papertrans.cn/c/image/224917.jpggregarious 发表于 2025-3-22 07:50:33
http://reply.papertrans.cn/23/2250/224917/224917_4.pngGraphite 发表于 2025-3-22 11:07:34
http://reply.papertrans.cn/23/2250/224917/224917_5.pnghieroglyphic 发表于 2025-3-22 13:07:24
http://reply.papertrans.cn/23/2250/224917/224917_6.pnghieroglyphic 发表于 2025-3-22 19:11:55
http://reply.papertrans.cn/23/2250/224917/224917_7.pngdapper 发表于 2025-3-22 23:09:20
http://reply.papertrans.cn/23/2250/224917/224917_8.pnggustation 发表于 2025-3-23 01:37:22
http://reply.papertrans.cn/23/2250/224917/224917_9.pngRLS898 发表于 2025-3-23 09:35:46
https://doi.org/10.1007/978-3-319-75118-4onspecific inhibitors of inflammation, such as corticosteroids, indicates our lack of understanding of the specific mechanisms that initiate and maintain these reactions. Therefore, it is important to identify novel mechanisms of activation and regulation that can lead to new therapeutics. Peribronc